Patel P - Search Results

1

An insight on medicinal attributes of 1,2,3- and 1,2,4-triazole derivatives as alpha-amylase and alpha-glucosidase inhibitors.

Sharma A, Dubey R, Bhupal R, Patel P, Verma SK, Kaya S, Asati V. Sharma A, et al. Among authors: patel p. Mol Divers. 2024 Oct;28(5):3605-3634. doi: 10.1007/s11030-023-10728-1. Epub 2023 Sep 21. Mol Divers. 2024. PMID: 37733243 Review.

2

Pyrazolopyrimidines as anticancer agents: A review on structural and target-based approaches.

Asati V, Anant A, Patel P, Kaur K, Gupta GD. Asati V, et al. Among authors: patel p. Eur J Med Chem. 2021 Dec 5;225:113781. doi: 10.1016/j.ejmech.2021.113781. Epub 2021 Aug 18. Eur J Med Chem. 2021. PMID: 34438126 Review.

3

Recent Progress in Histone Deacetylase (HDAC) 1 Inhibitors as Anticancer Agent.

Patel P, Wahan SK, Vishakha S, Kurmi BD, Gupta GD, Rajak H, Asati V. Patel P, et al. Curr Cancer Drug Targets. 2022;23(1):47-70. doi: 10.2174/1568009622666220624090542. Curr Cancer Drug Targets. 2022. PMID: 35747969 Review.

4

Recent updates on structural insights of MAO-B inhibitors: a review on target-based approach.

Baweja GS, Gupta S, Kumar B, Patel P, Asati V. Baweja GS, et al. Among authors: patel p. Mol Divers. 2024 Jun;28(3):1823-1845. doi: 10.1007/s11030-023-10634-6. Epub 2023 Mar 28. Mol Divers. 2024. PMID: 36977955 Free PMC article. Review.

5

Remediation of environmental toxicants using carbonaceous materials: opportunity and challenges.

Gill SS, Goyal T, Goswami M, Patel P, Das Gupta G, Verma SK. Gill SS, et al. Among authors: patel p. Environ Sci Pollut Res Int. 2023 Jun;30(27):69727-69750. doi: 10.1007/s11356-023-27364-9. Epub 2023 May 9. Environ Sci Pollut Res Int. 2023. PMID: 37160511 Review.

6

Current progress in the targeted therapy of breast cancer: Structure-activity correlation and docking studies (2015-2021).

Pandey S, Mondal S, Kajal K, Kurmi BD, Verma SK, Patel P. Pandey S, et al. Among authors: patel p. Arch Pharm (Weinheim). 2023 Aug;356(8):e2200602. doi: 10.1002/ardp.202200602. Epub 2023 May 21. Arch Pharm (Weinheim). 2023. PMID: 37211680 Review.

7

A Mini-review on Recent Strategies and Applications of Nanomedicines to Combat Antimicrobial Resistance.

Chahar K, Sharma Y, Patel P, Asati V, Das Kurmi B. Chahar K, et al. Among authors: patel p. Curr Drug Metab. 2023;24(6):406-421. doi: 10.2174/1389200224666230731093319. Curr Drug Metab. 2023. PMID: 37519199

8

An Expedition on Synthetic Methodology of FDA-approved Anticancer Drugs (2018-2021).

Vishakha S, Navneesh N, Kurmi BD, Gupta GD, Verma SK, Jain A, Patel P. Vishakha S, et al. Among authors: patel p. Anticancer Agents Med Chem. 2024;24(8):590-626. doi: 10.2174/0118715206259585240105051941. Anticancer Agents Med Chem. 2024. PMID: 38288815 Review.

9

Hydroxamic acid derivatives as selective HDAC3 inhibitors: computer-aided drug design strategies.

Patel P, Shrivastava SK, Sharma P, Kurmi BD, Shirbhate E, Rajak H. Patel P, et al. J Biomol Struct Dyn. 2024 Jan-Feb;42(1):362-383. doi: 10.1080/07391102.2023.2192804. Epub 2023 Mar 30. J Biomol Struct Dyn. 2024. PMID: 36995068

10

Current Medicinal Insights on Synthetic Small Molecules and Natural Origin Products as PD-1/PD-L1 Inhibitors.

Pandey S, Kurmi BD, Patel P. Pandey S, et al. Among authors: patel p. Curr Top Med Chem. 2023;23(18):1765-1781. doi: 10.2174/1568026623666230417111616. Curr Top Med Chem. 2023. PMID: 37070445 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

9,039 results

Search Page

Filters